Mahindra Manulife Focused Fund
The scheme seeks to generate long term capital appreciation by investing in a concentrated portfolio of equity & equity related instruments of maximum 30 companies across market capitalisation.
Growthvine rating: 5/5 — ranked #2 of 28 in category.
Fund basics
| Category | Equity: Focused |
|---|
| NAV | ₹24.75 (as of 2026-10-01) |
|---|
| AUM | ₹2,161 Cr |
|---|
| Expense ratio | 1.75% |
|---|
| Riskometer | Very High |
|---|
| Fund manager | Kirti Dalvi |
|---|
| Exit load | 1% for redemption within 3 months |
|---|
Performance & risk
| 5-year annualised return | 10.28% |
|---|
| Sharpe ratio | 0.59 |
|---|
| Standard deviation | 14.27% |
|---|
| Max drawdown | −17.03% |
|---|
| Alpha | 3.52 |
|---|
| Beta | 0.9 |
|---|
Over 5 years, captured 98.5% of Nifty 500's upside and 89.6% of its downside.
Market cap allocation
| Large cap | 84.3% |
|---|
| Mid cap | 10.0% |
|---|
| Small cap | 5.7% |
|---|
Concentration
| Top 5 holdings | 30.5% |
|---|
| Top 10 holdings | 51.3% |
|---|
| Total holdings | 30 |
|---|
| Index overlap | 31.8% |
|---|
| Active share | 68.2% |
|---|
Top holdings
- ICICI Bank Ltd. — 9.0%
- Reliance Industries Ltd — 6.3%
- State Bank Of India — 5.2%
- Larsen & Toubro Limited — 5.1%
- Grasim Industries Ltd — 4.9%
- AXIS Bank Ltd. — 4.7%
- Bajaj Auto Limited — 4.6%
- Bajaj Finance Limited — 4.3%
- Tech Mahindra Limited — 3.6%
- HDFC Bank Ltd. — 3.5%
Top sectors
- Banking & Financial — 27.1%
- Construction — 11.9%
- Pharma & Biotech — 8.0%
Calendar-year track record
| Year | Return | Quartile | Category rank |
|---|
| 2026 (partial) | −9.3% | Q4 (Bottom) | #25 of 28 |
| 2025 | 7.2% | Q2 | #10 of 28 |
| 2024 | 20.7% | Q2 | #10 of 27 |
| 2023 | 29.9% | Q1 (Top) | #5 of 25 |
| 2022 | 8.4% | Q1 (Top) | #4 of 22 |